Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: CABB 5y sr sec E420m fixed 8.75% at 100; E250m FRN E+525bp at 97.50

HYC European Market: Deal Flow - General

Monitchem Holdco 3 SA (CABB Group GmbH) (CABBCO) EUR670m 144A/Reg S sr sec fixed/floating notes 2-part. B3/B (stable/stable). Via BofA/DB/GS (B&D) jt physical books, Commerz as co-manager. No reg rights. List Lux. NY law. Settles 04/28 (T+6).

- EUR420m fixed rate notes due 05/01/28 (5y). NC2 (05/01/25) (MWC B+50bp), then at 104.275, 102.188, 100. Equity claw: 2y 40% at 108.75. Special call: 10% per year the first 2 years at 103. Pays June 15 and Dec 15, starting 12/15/23. Reg S ISIN: XS2515006470. IPT: 9% area. Px talk: 8.75%-9.00%. Priced: 8.75% at 100. +625bp vs Bund 0.5% 02/15/28.

- EUR250m FRN due 05/01/28 (5y). NC1 (05/01/2024) (MWC B+50bp), then at 101, 100. Floats/pays quarterly March 15, June 15, Sept 15, Dec 15, starting 09/15/23. Reg S ISIN: XS2615006983. IPT: E+525bp at 96-97. Px talk: 3mE+525bp at 97-97.50. Priced: 3mE+525bp (0% floor) at 97.50.

Roadshow 04/17-19 (investor call at 10:30am UKT 04/17). Books closed at 11am UKT today. UOP: along with EUR6m cash on hand, to redeem its existing EUR315m 5.25% sr sec 1st lien notes due 03/15/25 (callable at 101.313); EUR175m sr sec 1st lien FRN 03/15/25 (callable at 100); and holdco EUR150m 9.50% sr sub notes due 09/15/26 (callable at 104.75). Equity sponsor: Permira. Biz: leading crop science contract development and manufacturing (CDMO) and fine chemistry manufacturer, supplying customized active ingredients and high-complexity and high-purity chemical ingredients to customers in the life science and performance material markets. HQ: Sulzbach am Taunus, Germany.

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.